The treatment of HIV-1 infection using certain pyridodiazepines

US5571809A · kind A · utility

Assignee

• Boehringer Ingelheim Pharmaceuticals, Inc. · US

Inventors

• Karl D. Hargrave · Brookfield, US
• Gunther Schmidt · Biberach, DE
• Wolfhard Engel
• Gunther Trummlitz · Biberach, DE
• Wolfgang Eberlein · Biberach, DE

Key dates

• Filing date: Aug 17, 1994
• Grant date: Nov 5, 1996
• Expiry date: Aug 17, 2014

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D471/04
• WIPO field: Organic fine chemistry
• WIPO sector: Chemistry

Abstract

Disclosed are novel pyridodiazepines. These compounds, as well certain known 6,11-dihydro-5H-pyrido[2,3-b][1,5]benzodiazepin-5-ones are useful in the treatment of AIDS, ARC and related disorders associated with HIV infection.